Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 20, 2015In Europa sono stati eseguiti i primi impianti, che segnano l’inizio di una limitata immissione in commercio
Boston Scientific (NYSE: BSX) oggi ha annunciato che in seguito all’approvazione del marchio CE, in Europa sono stati eseguiti i primi impianti del dispositivo per la chiusura dell’auricola...
-
Nov 19, 2015First Implants Occur in Europe, Commencing Limited Market Release
Boston Scientific (NYSE: BSX) today announced that the first implants of the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device – the latest generation of the WATCHMAN Device –...
-
Nov 19, 2015Erste Implantationen nach begrenzter Markteinführung in Europa.
Boston Scientific Corporation (NYSE: BSX) hat heute bekanntgegeben, dass die ersten Implantationen des WATCHMAN FLX™, der neuesten Generation der WATCHMAN-Implantate zum Verschluss des linken...
-
Nov 19, 2015Comienza la comercialización con los primeros implantes en Europa.
Boston Scientific Corporation (NYSE: BSX) ha anunciado hoy la realización de los primeros implantes en Europa del dispositivo WATCHMAN FLX™ , de última generación, para el cierre de la...
-
Nov 9, 2015Topline data confirming peri-procedural safety of left atrial appendage (LAA) occlusion with the WATCHMAN™ Left Atrial Appendage (LAA) Closure device was presented in an oral session during the American Heart Association (AHA) Scientific Sessions.
This is the first study to collect real-world WATCHMAN LAA Closure Device experience outside of selected populations in randomized trials. Results from the prospective, multi-centre EWOLUTION...
-
Sep 29, 2015Sesión interactiva sobre asma grave. Contaremos con los principales expertos europeos en asma y podrás escuchar el testimonio de un paciente al que le cambió la vida
28 de Septiembre, 2015, 18:30 – 20:00 Wyndham Apollo Hotel Amsterdam (a 15 minutos de la sede del Congreso ERS) Agenda 18:30 Bienvenida y presentaciones Sue Mayor, Moderador 18:40 Descubriendo...
-
Sep 29, 2015Tanto el trabajo como la vida social y familiar se ven afectados por el asma grave; muchos pacientes refieren sentir ansiedad, depresión y aislamiento.
Boston Scientific ha revelado hoy los resultados de una encuesta exhaustiva, que muestra la verdadera carga y las dificultades diarias a las que se enfrentan las personas con asma en Europa....
-
Sep 28, 2015A media briefing with a difference: join us for this interactive session on severe asthma. Hear from Europe’s leading experts in asthma and visit our information stations to bring the story to life.
September 28, 2015, 18:30 – 20:00 Wyndham Apollo Hotel Amsterdam (15 minutes from the ERS Congress Venue, the Amsterdam RAI Exhibition and Convention Centre) Agenda 18:30 Welcome and scene...
-
Sep 28, 2015Work, social and family life all affected by severe asthma, many people report feelings of anxiety, depression and isolation as well
Boston Scientific today revealed results of a comprehensive survey which shows the true burden of severe asthma and the daily challenges faced by people with asthma in Europe. Uncovering Asthma, a...
-
Sep 28, 2015MAJESTIC Trial Data Support Strong Safety Profile with Low Target Lesion Revascularization Rate
New 12-month clinical trial outcomes assessing the safety and performance of the Boston Scientific (NYSE: BSX) Eluvia™ Drug-Eluting Vascular Stent System reflect a primary patency rate1 of more...